Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention

被引:88
作者
Kizer, JR
Muttrej, MR
Matthai, WH
McConnell, J
Nardone, H
Sonel, AF
Keane, MG
Wilensky, RL
机构
[1] Cornell Univ, Weill Med Coll, Dept Med & Publ Hlth, Div Cardiol, New York, NY USA
[2] Univ Penn, Sch Med, Div Cardiovasc, Dept Med, Philadelphia, PA 19104 USA
[3] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA
[4] Univ Pittsburgh, Sch Med, Dept Med, Div Cardiol, Pittsburgh, PA USA
关键词
angioplasty; creatine kinase; myocardial infarction;
D O I
10.1016/S0195-668X(03)00258-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate the long-term prognostic significance of pre- and post-procedure troponin T (TnT) elevations in patients undergoing percutaneous coronary intervention (PCI). Methods and results TnT and CK-MB were measured pre- and post-procedure in 212 patients undergoing PCI. Major adverse events (composite of death, myocardial infarction and revascutarization) were ascertained 6 years later. Pre-procedural TnT was a significant independent predictor of time to major events (hazard ratio [HR] 1.75, 95% confidence interval [CI] 1.16-2.64) and death or myocardial infarction. Post-procedural TnT elevation above normal was the only independent predictor of the primary end-point at 1 year (HR 2.39, 95% CI 1.09-5.26) but was not significantly related to event-free survival throughout follow-up. Post-PCI elevation of TnT 5x above normal, however, did significantly predict time to events during the entirety of follow-up. By contrast, CK-MB was not an independent predictor in any of the analyses. Conclusions Our study confirms the long-term prognostic value of pre-procedural TnT elevation in patients undergoing PCI, and demonstrates the superior predictive ability of a post-procedural increase in TnT 5x normal for tong-term adverse events. Whether the prognostic significance of smaller post-procedural TnT elevations extends beyond the intermediate-term awaits further investigation. (C) 2003 Published by Elsevier Ltd on behalf of The European Society of Cardiology.
引用
收藏
页码:1314 / 1322
页数:9
相关论文
共 31 条
[1]   Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions [J].
Abdelmeguid, AE ;
Topol, EJ ;
Whitlow, PL ;
Sapp, SK ;
Ellis, SG .
CIRCULATION, 1996, 94 (07) :1528-1536
[2]   Minor myocardial damage and prognosis - Are spontaneous and percutaneous coronary intervention-related events different? [J].
Akkerhuis, KM ;
Alexander, JH ;
Tardiff, BE ;
Boersma, E ;
Harrington, RA ;
Lincoff, AM ;
Simoons, ML .
CIRCULATION, 2002, 105 (05) :554-556
[3]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[4]  
[Anonymous], 1979, Circulation, V59, P607
[5]  
[Anonymous], MODELLING SURVIVAL D
[6]   Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris [J].
Bertinchant, JP ;
Polge, A ;
Ledermann, B ;
Genet, L ;
Fabbro-Peray, P ;
Raczka, F ;
Brunet, J ;
Poirey, S ;
Wittenberg, O ;
Pernel, I ;
Nigond, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (01) :51-57
[7]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[8]   Prognostic significance of elevated troponin I after percutaneous coronary intervention [J].
Cantor, WJ ;
Newby, LK ;
Christenson, RH ;
Tuttle, RH ;
Hasselblad, V ;
Armstrong, PW ;
Moliterno, DJ ;
Califf, RM ;
Topol, EJ ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1738-1744
[9]   Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: Angiographic correlates and long-term clinical outcomes [J].
deFilippi, CR ;
Tocchi, P ;
Parmar, RJ ;
Rosanio, S ;
Abreo, G ;
Potter, MA ;
Runge, MS ;
Uretsky, BF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (07) :1827-1834
[10]   Death following creatine kinase-MB elevation after coronary intervention - Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy [J].
Ellis, SG ;
Chew, D ;
Chan, A ;
Whitlow, PL ;
Schneider, JP ;
Topol, EJ .
CIRCULATION, 2002, 106 (10) :1205-1210